SURPASS-5 (NCT04039503) is a 40-week, multi-center, randomized, double-blind trial evaluating the efficacy and safety of tirzepatide compared to placebo in adults with inadequately controlled type 2 diabetes already being treated with insulin glargine, with or without metformin
Staying hydrated helps protect your kidneys and reduces the risk of both kidney stones and severe nausea
AulingerBABedorfAKutscherauerGdeHeer JHolstJJGkeBet al
Weight Loss That Lasts: Reviewing the Long-Term Impact of GLP-1 Receptor Agonists
For example, variants in the MC4R gene are associated with how your body regulates satiety and energy expenditure, which can affect how much protein keeps you satisfied
Exenatide for weight-loss maintenance in adolescents with severe obesity: A randomized, placebo-controlled trial